Business Description
McKesson Corp
NAICS : 424210
SIC : 5122
ISIN : US58155Q1031
Share Class Description:
FRA:MCK: Ordinary SharesTotal Employee Number:
43,000Compare
Compare
Traded in other countries / regions
MCK.USA0JZU.UKM1CK34.BrazilMCK.MexicoMCK.Germany1MCK.Italy IPO Date
1987-08-03Description
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | -0.03 | |||||
Debt-to-Equity | -3.97 | |||||
Debt-to-EBITDA | 1.2 | |||||
Interest Coverage | 26.13 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.12 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.7 | |||||
3-Year EBITDA Growth Rate | 14.4 | |||||
3-Year EPS without NRI Growth Rate | 18.4 | |||||
3-Year FCF Growth Rate | 10.4 | |||||
3-Year Book Growth Rate | -9.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.56 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.41 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.18 | |||||
9-Day RSI | 58.46 | |||||
14-Day RSI | 58.97 | |||||
3-1 Month Momentum % | -6.29 | |||||
6-1 Month Momentum % | -4.15 | |||||
12-1 Month Momentum % | 4.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.85 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 23.55 | |||||
Days Sales Outstanding | 23.74 | |||||
Days Payable | 55.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.38 | |||||
Dividend Payout Ratio | 0.08 | |||||
3-Year Dividend Growth Rate | 14.9 | |||||
Forward Dividend Yield % | 0.44 | |||||
5-Year Yield-on-Cost % | 0.73 | |||||
3-Year Average Share Buyback Ratio | 4.1 | |||||
Shareholder Yield % | 3.74 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 3.61 | |||||
Operating Margin % | 1.6 | |||||
Net Margin % | 1.18 | |||||
EBITDA Margin % | 1.78 | |||||
FCF Margin % | 1.34 | |||||
OCF Margin % | 1.52 | |||||
ROE % | Neg. Equity | |||||
ROA % | 5.85 | |||||
ROIC % | 21.04 | |||||
3-Year ROIIC % | 21.99 | |||||
ROC (Joel Greenblatt) % | 139.81 | |||||
ROCE % | 41.33 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.26 | |||||
Forward PE Ratio | 19.43 | |||||
PE Ratio without NRI | 21.87 | |||||
Shiller PE Ratio | 66.54 | |||||
Price-to-Owner-Earnings | 20.45 | |||||
PS Ratio | 0.26 | |||||
Price-to-Free-Cash-Flow | 19.49 | |||||
Price-to-Operating-Cash-Flow | 17.15 | |||||
EV-to-EBIT | 16.47 | |||||
EV-to-Forward-EBIT | 14.82 | |||||
EV-to-EBITDA | 14.8 | |||||
EV-to-Forward-EBITDA | 13.38 | |||||
EV-to-Revenue | 0.26 | |||||
EV-to-Forward-Revenue | 0.24 | |||||
EV-to-FCF | 19.63 | |||||
Price-to-GF-Value | 1.07 | |||||
Price-to-Projected-FCF | 1.52 | |||||
Price-to-Median-PS-Value | 1.52 | |||||
Earnings Yield (Greenblatt) % | 6.07 | |||||
FCF Yield % | 5.4 | |||||
Forward Rate of Return (Yacktman) % | -18.48 |
McKesson Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
McKesson Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2027-02-04 16:30 | In 185 days | ||
| Third quarter earnings results for 2027 | 2027-02-04 | In 184 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-05 16:30 | In 94 days | ||
| Second quarter earnings results for 2027 | 2026-11-05 | In 93 days | ||
| USD 0.940000 Cash Dividend | 2026-09-01 | In 28 days | ||
| First quarter earnings conference call for 2027 | 2026-08-05 16:30 | In 2 days | ||
| First quarter earnings results for 2027 | 2026-08-05 | In 1 day | ||
| General meeting for 2026 | 2026-07-22 08:30 | 723.00 (+0.00%) | ||
| USD 0.820000 Cash Dividend | 2026-06-01 | 645.00 (+0.00%) | ||
| Annual report for 2026 | 2026-05-08 | 628.20 (+0.03%) |
Show
Entries
Press Release
Articles on McKesson Corp
No articles.